secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001493152-24-023859
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience Q3 net product sales $440K, net loss $857K; loss per share ($0.01)
--------------------------------------------------------------------------------

- Net product sales $440,000 for Q3 FY2024, up 8% vs $406,000 in prior-year quarter.
- Net loss $857,000; narrower than $876,000 in Q3 FY2023; net loss per share unchanged ($0.01).
- For the nine months ended April 30, 2024, net product sales $1,483,000, net loss $2,594,000.
- Company transitioning to distributor model; new Tier Pricing Agreement developed for distributor margins.
- Social media platform engagement up 167% in past 90 days; followers up nearly 70%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315224023859/0001493152-24-023859-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315224023859/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023859

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer